The novel BCL-2/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer.
新型 BCL-2/BCL-XL 抑制剂 APG-1252 介导的 GSDME 裂解增强了 HER2 靶向治疗在 HER2 阳性胃癌中的抗肿瘤疗效
期刊:Acta Pharmacologica Sinica
影响因子:8.4
doi:10.1038/s41401-024-01414-5
Luo Qiu-Yun, Yang Jing, Di Tian, Xia Zeng-Fei, Zhang Lin, Pan Wen-Tao, Shi Shan, Yang Li-Qiong, Sun Jian, Qiu Miao-Zhen, Yang Da-Jun